118 related articles for article (PubMed ID: 3657156)
1. Studies on aromatase inhibition with 4-androstene-3,6,17-trione: its 3 beta-reduction and time-dependent irreversible binding to aromatase with human placental microsomes.
Numazawa M; Tsuji M; Mutsumi A
J Steroid Biochem; 1987 Sep; 28(3):337-44. PubMed ID: 3657156
[TBL] [Abstract][Full Text] [Related]
2. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity.
Covey DF; Hood WF
Endocrinology; 1981 Apr; 108(4):1597-9. PubMed ID: 7472286
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inactivation by a suicide substrate, androst-5-ene-4,7,17-trione: the 5beta,6beta-epoxy-19-oxo derivative, as a possible reactive electrophile irreversibly binding to the active site.
Numazawa M; Tachibana M
Biol Pharm Bull; 1997 May; 20(5):490-5. PubMed ID: 9178927
[TBL] [Abstract][Full Text] [Related]
5. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
6. A time-dependent inactivation of aromatase by 19-substituted androst-4-ene-3,6,17-triones.
Numazawa M; Mutsumi A; Asano N; Ito Y
Steroids; 1993 Jan; 58(1):40-6. PubMed ID: 8430444
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of bromoacetoxy 4-androsten-3-ones as active site-directed inhibitors of human placental aromatase.
Numazawa M; Tsuji M; Osawa Y
Steroids; 1986; 48(5-6):347-59. PubMed ID: 3445287
[TBL] [Abstract][Full Text] [Related]
8. A time-dependent inactivation of aromatase by 19-oxygenated androst-4-ene-3,6,17-triones.
Numazawa M; Mutsumi A; Hoshi K; Kigawa H; Oshibe M
J Steroid Biochem Mol Biol; 1991 Dec; 39(6):959-66. PubMed ID: 1751396
[TBL] [Abstract][Full Text] [Related]
9. Metabolic aspects of the 1 beta-proton and the 19-methyl group of androst-4-ene-3,6,17-trione during aromatization by placental microsomes and inactivation of aromatase.
Numazawa M; Midzuhashi K; Nagaoka M
Biochem Pharmacol; 1994 Feb; 47(4):717-26. PubMed ID: 8129748
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a new androstenedione derivative, 14 alpha-hydroxy-4-androstene-3,6,17-trione (14 alpha-OHAT) on aromatase activity of human uterine tumors.
Yamamoto T; Fukuoka M; Fujimoto Y; Kitawaki J; Nakakoshi M; Yoshihama M; Okada H
J Steroid Biochem; 1990 Aug; 36(6):517-21. PubMed ID: 2214767
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
13. 6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors.
Numazawa M; Mutsumi A
Biochem Biophys Res Commun; 1991 May; 177(1):401-6. PubMed ID: 2043124
[TBL] [Abstract][Full Text] [Related]
14. Biochemical studies of estr-4-ene-3,6,17-trione and 5 alpha-androstan-17-ones with or without a carbonyl function at C-3 and/or C-6 as aromatase inhibitors.
Numazawa M; Mutsumi A; Tachibana M; Nagaoka M
Biol Pharm Bull; 1995 Apr; 18(4):555-8. PubMed ID: 7655426
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
16. 7-substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
Li PK; Brueggemeier RW
J Steroid Biochem; 1990 Aug; 36(6):533-9. PubMed ID: 2214770
[TBL] [Abstract][Full Text] [Related]
17. Studies of the inactivation of human placental aromatase by 17 alpha-ethynyl-substituted 10 beta-hydroperoxy and related 19-nor steroids.
Covey DF; Hood WF; McMullan PC
Biochem Pharmacol; 1986 May; 35(10):1671-4. PubMed ID: 3707596
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
20. The constitutive 7-ethoxycoumarin O-deethylase activity of human placental microsomes: relationship to aromatase.
Meigs RA
Biochem Biophys Res Commun; 1987 Jun; 145(3):1012-8. PubMed ID: 3496877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
